共 50 条
- [21] A role of antifibrotics in the treatment of Scleroderma-ILD? PULMONOLOGY, 2020, 26 (01): : 1 - 2
- [22] T-889C IL-1α promoter polymorphism influences the response to oral cyclophosphamide in scleroderma patients with alveolitis Clinical Rheumatology, 2007, 26 : 88 - 91
- [24] Scleroderma Renal Crisis Associated With Microangiopathic Hemolytic Anemia in a Patient With Seronegative Scleroderma and Monoclonal Gammopathy JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2022, 10